TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Two patients described in a MedPage Today report obtained insurance approval after taking disputes over denied or out-of-network care to company executives. Former insurance executive Wendell Potter said senior-level appeals can draw attention, but the cases do not establish how often the tactic works or whether it is appropriate for every patient.
Two patients whose care faced insurance barriers secured approval after contacting company executives, according to a MedPage Today report published October 8. The cases, highlighted by former insurance executive Wendell Potter, suggest that escalating a dispute to senior leaders can attract attention, but do not show how often the approach succeeds.
One case involved Elizabeth Nicholas, who was diagnosed with breast cancer at 36. After months of treatment, her insurer refused to cover the type of chemotherapy recommended by her oncologist. Nicholas emailed the company’s CEO; she later received a message from its chief scientific officer saying the treatment had been approved. Her experience had also been described in a Vanity Fair article the previous month, according to MedPage Today.
The second case involved Donald E. Grant Jr., 49, who has severe congenital cervical stenosis. After an earlier two-level artificial disc replacement did not adequately decompress his spinal cord, he developed myelomalacia, the report said. Grant had a procedure scheduled with Hyun Bae, a Cedars-Sinai spine surgeon he considered particularly qualified to treat his condition, but Bae was outside Grant’s insurance network.
Grant used the AI-assisted appeal platform Claimable to prepare an 11-page appeal. It argued that his plan lacked an in-network surgeon with comparable qualifications, cited regulations and asked the insurer not to use algorithms to decide the case. He sent the appeal to UnitedHealth Group’s CEO and copied company leaders, legislators and journalists. UnitedHealthcare approved the procedure with Bae at the in-network rate, MedPage Today reported.
When Denials Reach Senior Leaders
The cases illustrate one route patients may try after ordinary claim or appeal channels fail: raising a dispute with company leadership. Potter told MedPage Today that insurers have staff who handle high-profile cases brought to the C-suite or public-relations departments, and said those cases can receive special attention. That perspective comes from his experience as a former insurance executive, not from evidence that executive emails routinely change coverage decisions.
For patients, the examples also show the amount of work that escalation can require. Grant’s appeal involved research, a lengthy written argument and support from an AI-assisted service. Nicholas’s dispute became the subject of a published article. The outcomes may encourage patients and clinicians to look for additional channels, but they do not establish a standard process or guarantee a favorable decision.
Potter also warned that clinicians who repeatedly challenge insurers may face consequences, including possible network exclusion. The report provides no details about a specific clinician being removed from a network in these cases. The broader issue is that access to care may depend on patients’ ability to navigate appeals and reach decision-makers, rather than on a clear, dependable route to review.
AI-assisted insurance appeal platform
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How the Two Appeals Reached Executives
The report presents the cases as two recent examples, not a survey or analysis of insurer decisions. Nicholas’s experience received attention through a Vanity Fair article and then was cited by Potter in his newsletter, Health Care Un-Covered. Potter said that when he worked at Cigna, cases being investigated by reporters were elevated within the company.
Grant’s dispute centered on an out-of-network surgeon, while the rest of the operation was covered in-network, according to the report. His appeal made a case for an exception based on the absence of a comparably qualified in-network surgeon. MedPage Today said UnitedHealthcare approved the procedure at the in-network rate. These details describe the circumstances of one approval; they do not show that similar requests will receive the same outcome.
Both examples were discussed by Potter, who advised patients not to treat an initial denial as final. The report also quoted Eagan Kemp, a healthcare policy advocate at Public Citizen, criticizing the burden placed on patients and providers. Kemp linked that frustration to support for Medicare-for-All, which he said would remove insurance middlemen. That is Kemp’s policy argument, not a finding established by the two cases.
“You can be certain that at big insurance companies, there is a group of people around the CEO who are dedicated to high-profile cases and cases that are elevated to the C-suite or to the PR department — and they get special attention.”
— Wendell Potter, former insurance company executive, speaking to MedPage Today
What Two Cases Cannot Establish
The report does not provide data on how frequently CEO emails succeed, how many similar messages fail, or how these two outcomes compare with ordinary appeals. It also does not establish whether the patients’ executive contacts alone caused the approvals. Nicholas’s case involved media coverage, while Grant sent his appeal to several audiences, including company leaders, lawmakers and journalists.
Details about the insurers’ internal review processes and the specific reasons for each approval are not given. The report also does not assess Claimable’s accuracy or effectiveness beyond describing its role in helping Grant assemble his appeal. Patients considering a dispute may face different policy terms, medical circumstances and appeal deadlines.
Potter’s warning about network consequences is his stated concern; the article does not report such a consequence in these cases. More broadly, the examples do not answer whether insurers have a consistent, accessible process for reviewing escalated complaints or how patients without time, support or specialist knowledge can pursue one.
Appeals Continue Through Existing Channels
The report does not identify a scheduled policy change, new insurer process or further milestone arising from the two cases. Patients with coverage disputes will still need to consult the procedures and deadlines that apply to their plans; an email to an executive is presented here as an additional tactic, not a replacement for formal appeals.
Potter said patients and clinicians should not treat a denial as necessarily final, while acknowledging that escalation should not be required to obtain care. Whether more patients or providers adopt the approach—and whether insurers respond with formal changes—remains unknown. Any broader conclusion about its effectiveness would require information beyond these two reported outcomes.
Key Questions
What happened in the two cases?
Both patients obtained approval after disputes reached insurance company leadership. Elizabeth Nicholas received approval for the chemotherapy her oncologist recommended after emailing her insurer’s CEO. Donald E. Grant Jr. obtained approval for a procedure with an out-of-network surgeon at the in-network rate after sending a detailed appeal to UnitedHealth Group’s CEO and others, according to MedPage Today.
Does emailing an insurance CEO guarantee approval?
No. The report describes two successful cases but provides no data on the success rate of executive emails or how often they fail. It also does not establish that contacting executives alone caused either approval.
What did Grant include in his appeal?
Grant used Claimable, an AI-assisted appeal platform, to prepare an 11-page document. It argued that his plan had no in-network surgeon with comparable qualifications, cited regulations and requested that algorithms not be used to determine his case.
What risk did Potter identify for doctors?
Potter warned that a doctor who frequently challenges insurers could annoy a company and risk being removed from its network. The report presents this as Potter’s caution; it does not say that either case resulted in a clinician being removed.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
